155 related articles for article (PubMed ID: 24836549)
1. Association between l-thyroxine treatment, GH deficiency, and radiological vertebral fractures in patients with adult-onset hypopituitarism.
Mazziotti G; Mormando M; Cristiano A; Bianchi A; Porcelli T; Giampietro A; Maffezzoni F; Serra V; De Marinis L; Giustina A
Eur J Endocrinol; 2014 Jun; 170(6):893-9. PubMed ID: 24836549
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency.
Mazziotti G; Porcelli T; Bianchi A; Cimino V; Patelli I; Mejia C; Fusco A; Giampietro A; De Marinis L; Giustina A
Eur J Endocrinol; 2010 Jul; 163(1):15-20. PubMed ID: 20378720
[TBL] [Abstract][Full Text] [Related]
3. Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency.
Mazziotti G; Doga M; Frara S; Maffezzoni F; Porcelli T; Cerri L; Maroldi R; Giustina A
Endocrine; 2016 Apr; 52(1):103-10. PubMed ID: 26433736
[TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy.
Mazziotti G; Bianchi A; Bonadonna S; Nuzzo M; Cimino V; Fusco A; De Marinis L; Giustina A
J Bone Miner Res; 2006 Apr; 21(4):520-8. PubMed ID: 16598371
[TBL] [Abstract][Full Text] [Related]
5. Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency.
Mazziotti G; Bianchi A; Cimino V; Bonadonna S; Martini P; Fusco A; De Marinis L; Giustina A
Pituitary; 2008; 11(1):55-61. PubMed ID: 17965964
[TBL] [Abstract][Full Text] [Related]
6. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
[TBL] [Abstract][Full Text] [Related]
7. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
Agha A; Walker D; Perry L; Drake WM; Chew SL; Jenkins PJ; Grossman AB; Monson JP
Clin Endocrinol (Oxf); 2007 Jan; 66(1):72-7. PubMed ID: 17201804
[TBL] [Abstract][Full Text] [Related]
8. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
[TBL] [Abstract][Full Text] [Related]
9. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
10. Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients.
Klose M; Marina D; Hartoft-Nielsen ML; Klefter O; Gavan V; Hilsted L; Rasmussen AK; Feldt-Rasmussen U
J Clin Endocrinol Metab; 2013 Sep; 98(9):3802-10. PubMed ID: 23796569
[TBL] [Abstract][Full Text] [Related]
11. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement.
Attanasio AF; Mo D; Erfurth EM; Tan M; Ho KY; Kleinberg D; Zimmermann AG; Chanson P;
J Clin Endocrinol Metab; 2010 Jan; 95(1):74-81. PubMed ID: 19897679
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.
Verhelst J; Mattsson AF; Luger A; Thunander M; Góth MI; Koltowska-Häggström M; Abs R
Eur J Endocrinol; 2011 Dec; 165(6):881-9. PubMed ID: 21969523
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy.
Nishizawa H; Iguchi G; Murawaki A; Fukuoka H; Hayashi Y; Kaji H; Yamamoto M; Suda K; Takahashi M; Seo Y; Yano Y; Kitazawa R; Kitazawa S; Koga M; Okimura Y; Chihara K; Takahashi Y
Eur J Endocrinol; 2012 Jul; 167(1):67-74. PubMed ID: 22535644
[TBL] [Abstract][Full Text] [Related]
15. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
Drake WM; Coyte D; Camacho-Hübner C; Jivanji NM; Kaltsas G; Wood DF; Trainer PJ; Grossman AB; Besser GM; Monson JP
J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
[TBL] [Abstract][Full Text] [Related]
16. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
Götherström G; Bengtsson BA; Bosaeus I; Johannsson G; Svensson J
Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
[TBL] [Abstract][Full Text] [Related]
17. Effect of thyroxine replacement on serum IGF-I, IGFBP-3 and the acid-labile subunit in patients with hypothyroidism and hypopituitarism.
Schmid C; Zwimpfer C; Brändle M; Krayenbühl PA; Zapf J; Wiesli P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):706-11. PubMed ID: 17121519
[TBL] [Abstract][Full Text] [Related]
18. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density.
Wüster C; Abs R; Bengtsson BA; Bennmarker H; Feldt-Rasmussen U; Hernberg-Ståhl E; Monson JP; Westberg B; Wilton P;
J Bone Miner Res; 2001 Feb; 16(2):398-405. PubMed ID: 11204440
[TBL] [Abstract][Full Text] [Related]
19. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency.
Rosén T; Wilhelmsen L; Landin-Wilhelmsen K; Lappas G; Bengtsson BA
Eur J Endocrinol; 1997 Sep; 137(3):240-5. PubMed ID: 9330587
[TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).
Popovic V; Mattsson AF; Gaillard RC; Wilton P; Koltowska-Häggström M; Ranke MB
J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
